MOONSTONE/GOG-3032: A phase II, open-label, single-arm study to evaluate the efficacy and safety of niraparib plus dostarlimab in patients with platinum-resistant ovarian cancer-MedSci.cn

MOONSTONE/GOG-3032: A phase II, open-label, single-arm study to evaluate the efficacy and safety of niraparib plus dostarlimab in patients with platinum-resistant ovarian cancer

Randall, LM; O'Malley, DM; Monk, BJ; Coleman, RL; O'Cearbhaill, RE; Gaillard, S; Adams, S; Cappuccini, F; Huang, M; Chon, HS; Secord, AA; Arora, S; Keeton, E; Gupta, D; Samnotra, V; Konstantinopoulos, P

ANNALS OF ONCOLOGY, 2020; 31 (): S646

科室
- - 订阅+
  - 更多科室
工具
服务